Publications by authors named "Thierry Fontanges"

Claim this Profile
P
Predictive Factors for HBsAg Loss in Chronic HBeAg-Negative Hepatitis B Virus Infection: Insights From a 5-Year French Cohort.
Xavier Causse, Pascal Potier, Antoine Valéry, Hélène Labadie, Gilles Macaigne, Thierry Fontanges

J Viral Hepat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the HBV liver reservoir with fine needle aspirates.
Barbara Testoni, Armando Andres Roca Suarez, Arianna Battisti, Marie-Laure Plissonnier, Marintha Heil, Thierry Fontanges

JHEP Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenoma detection with blue-water infusion colonoscopy: a randomized trial.
Adriane Lesne, Olivier Rouquette, Sandrine Touzet, Fabien Petit-Laurent, Gwenaelle Tourlonias, Thierry Fontanges

Endoscopy· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia.
Mathilde Di Filippo, Philippe Moulin, Pascal Roy, Marie Elisabeth Samson-Bouma, Sophie Collardeau-Frachon, Thierry Fontanges

J Hepatol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Christophe Hézode, Helene Fontaine, Celine Dorival, Fabien Zoulim, Dominique Larrey, Thierry Fontanges

Gastroenterology· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of treatment with direct-acting antiviral (DAA) in clinical practice.
Thierry Fontanges

Clin Res Hepatol Gastroenterol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study.
Patrick Marcellin, Michel Chousterman, Thierry Fontanges, Denis Ouzan, Michel Rotily

Liver Int· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Fluorouracil-induced Tako-Tsubo-like syndrome.
Cécile Basselin, Thierry Fontanges, Jacques Descotes, Philippe Chevalier, Bernard Bui-Xuan

Pharmacotherapy· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients.
Patrick Marcellin, Jean-François Cadranel, Thierry Fontanges, Thierry Poynard, Stanislas Pol

Eur J Gastroenterol Hepatol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated interferon-alpha2b plus ribavirin therapy in patients with hepatitis C and psychiatric disorders: results of a cohort study.
Jean-Philippe Lang, Pascal Melin, Denis Ouzan, Michel Rotily, Thierry Fontanges

Antivir Ther· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study.
Pascal Melin, Michel Chousterman, Thierry Fontanges, Denis Ouzan, Michel Rotily

Eur J Gastroenterol Hepatol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: a prospective, real-life, observational study.
Patrice Cacoub, Denis Ouzan, Pascal Melin, Jean-Philippe Lang, Michel Rotily, Thierry Fontanges

World J Gastroenterol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Maintenance therapy for chronic hepatitis C].
Christian Trépo, Anne-Marie Marion-Audibert, Didier Samuel, Dominique Guyader, Thierry Fontanges

Gastroenterol Clin Biol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of combination therapy with peginterferon alfa-2a (40kD) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection.
Thierry Fontanges, Sylvain Beorchia, Catherine Douvin, Patrick Delassalle, Jean-Marc Combis

Gastroenterol Clin Biol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study.
Jean-François Cadranel, Jean-Louis Boujenah, Marc Bourlière, Thierry Fontanges, Stanislas Pol

Gastroenterol Clin Biol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis